Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

Hallvard Holdaas; Bengt Fellström; Alan G. Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen‐Riska; Sören Madsen; Hans‐Hellmut Neumayer; Edward Cole; Bart Maes; Patrice M. Ambühl; Anders Olsson; Anders Hartmann; D. Solbu; Terje R. Pedersen

doi:10.1016/s0140-6736(03)13638-0

Keywords

FluvastatinMedicineClinical endpointMyocardial infarctionPlaceboInternal medicinePopulationCardiologyAdverse effectRandomized controlled trialSimvastatin

Affiliated Institutions

Related Publications

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd , Gerard J. Blauw , Michael Murphy +17 more

Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Ou...

2002 The Lancet 3358 citations

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Patrick W. Serruys

Fluvastatin treatment in patients with average cholesterol levels undergoing their first successful PCI significantly reduces the risk of major adverse cardiac events.

2002 JAMA 709 citations

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>

Terje R. Pedersen

In this study of patients with previous MI, intensive lowering of LDL-C did not result in a significant reduction in the primary outcome of major coronary events, but did reduce...

2005 JAMA 1539 citations

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes

James A. de Lemos , Michael A. Blazing , Stephen D. Wiviott +14 more

2][3] More recently, 2 ran-domized controlled trials have evaluated earlier initiation of statin therapy following an ACS event and have noted a corresponding early reduction in...

2004 JAMA 1317 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

Publication Info

Year: 2003
Type: article
Volume: 361
Issue: 9374
Pages: 2024-2031
Citations: 918
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

918

OpenAlex

Cite This

APA Style

                            
                                
                                    Hallvard Holdaas, 
                                
                                    Bengt Fellström, 
                                
                                    Alan G. Jardine
                                
                                et al.
                            
                            (2003). 
                            Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. 
                            The Lancet
                            , 361
                            (9374)
                            , 2024-2031.
                            https://doi.org/10.1016/s0140-6736(03)13638-0
                        

Identifiers

DOI: 10.1016/s0140-6736(03)13638-0